BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ahmed-Hassan H, Sisson B, Shukla RK, Wijewantha Y, Funderburg NT, Li Z, Hayes D Jr, Demberg T, Liyanage NPM. Innate Immune Responses to Highly Pathogenic Coronaviruses and Other Significant Respiratory Viral Infections. Front Immunol 2020;11:1979. [PMID: 32973803 DOI: 10.3389/fimmu.2020.01979] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
Number Citing Articles
1 Matsuda M, Funakubo Asanuma Y, Yokota K, Sakai S, Yazawa H, Maruyama T, Tsuzuki Wada T, Araki Y, Mimura T. New-onset Adult-onset Still's Disease Following COVID-19 Vaccination: Three Case Reports and a Literature Review. Intern Med 2023;62:299-305. [PMID: 36351580 DOI: 10.2169/internalmedicine.0590-22] [Reference Citation Analysis]
2 Chen X, Li H, Song H, Wang J, Zhang X, Han P, Wang X. Meet changes with constancy: Defence, antagonism, recovery, and immunity roles of extracellular vesicles in confronting SARS-CoV-2. J Extracell Vesicles 2022;11:e12288. [PMID: 36450704 DOI: 10.1002/jev2.12288] [Reference Citation Analysis]
3 Teklemariam AD, Hashem AM, Saber SH, Almuhayawi MS, Haque S, Abujamel TS, Harakeh S. Bacterial co-infections and antimicrobial resistance associated with the Coronavirus Disease 2019 infection. Biotechnol Genet Eng Rev 2022;:1-22. [PMID: 36123822 DOI: 10.1080/02648725.2022.2122297] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Khalid Z, Huan M, Sohail Raza M, Abbas M, Naz Z, Kombe Kombe AJ, Zeng W, He H, Jin T. Identification of Novel Therapeutic Candidates Against SARS-CoV-2 Infections: An Application of RNA Sequencing Toward mRNA Based Nanotherapeutics. Front Microbiol 2022;13:901848. [DOI: 10.3389/fmicb.2022.901848] [Reference Citation Analysis]
5 Al-Beltagi M, Saeed NK, Bediwy AS. COVID-19 disease and autoimmune disorders: A mutual pathway. World J Methodol 2022; 12(4): 200-223 [DOI: 10.5662/wjm.v12.i4.200] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
6 Zoulikha M, Huang F, Wu Z, He W. COVID-19 inflammation and implications in drug delivery. J Control Release 2022;346:260-74. [PMID: 35469984 DOI: 10.1016/j.jconrel.2022.04.027] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Mouro V, Fischer A. Dealing with a mucosal viral pandemic: lessons from COVID-19 vaccines. Mucosal Immunol 2022. [PMID: 35505121 DOI: 10.1038/s41385-022-00517-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
8 Biswas M, Sawajan N, Rungrotmongkol T, Sanachai K, Ershadian M, Sukasem C. Pharmacogenetics and Precision Medicine Approaches for the Improvement of COVID-19 Therapies. Front Pharmacol 2022;13:835136. [DOI: 10.3389/fphar.2022.835136] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
9 de Carvalho Lima EN, Octaviano ALM, Piqueira JRC, Diaz RS, Justo JF. Coronavirus and Carbon Nanotubes: Seeking Immunological Relationships to Discover Immunotherapeutic Possibilities. IJN 2022;Volume 17:751-81. [DOI: 10.2147/ijn.s341890] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Barman B, Sahoo D, Khangembam A, Jamil M, Ish P. New-Onset rheumatoid arthritis following ChAdOx1 nCoV-19 vaccine administration. Indian J Rheumatol 2022;0:0. [DOI: 10.4103/injr.injr_51_22] [Reference Citation Analysis]
11 Alefishat E, Jelinek HF, Mousa M, Tay GK, Alsafar HS. Immune response to SARS-CoV-2 Variants: A focus on severity, susceptibility, and preexisting immunity. Journal of Infection and Public Health 2022. [DOI: 10.1016/j.jiph.2022.01.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
12 Jeon YH, Lim DH, Choi SW, Choi SJ. A flare of Still's disease following COVID-19 vaccination in a 34-year-old patient. Rheumatol Int 2021. [PMID: 34797392 DOI: 10.1007/s00296-021-05052-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
13 Koushki K, Salemi M, Miri SM, Arjeini Y, Keshavarz M, Ghaemi A. Role of myeloid-derived suppressor cells in viral respiratory infections; Hints for discovering therapeutic targets for COVID-19. Biomed Pharmacother 2021;144:112346. [PMID: 34678727 DOI: 10.1016/j.biopha.2021.112346] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
14 Han F, Liu Y, Mo M, Chen J, Wang C, Yang Y, Wu J. Current treatment strategies for COVID‑19 (Review). Mol Med Rep 2021;24:858. [PMID: 34664677 DOI: 10.3892/mmr.2021.12498] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
15 Fricke-Galindo I, Falfán-Valencia R. Genetics Insight for COVID-19 Susceptibility and Severity: A Review. Front Immunol 2021;12:622176. [PMID: 33868239 DOI: 10.3389/fimmu.2021.622176] [Cited by in Crossref: 55] [Cited by in F6Publishing: 57] [Article Influence: 27.5] [Reference Citation Analysis]
16 López-Cortés A, Guevara-Ramírez P, Kyriakidis NC, Barba-Ostria C, León Cáceres Á, Guerrero S, Ortiz-Prado E, Munteanu CR, Tejera E, Cevallos-Robalino D, Gómez-Jaramillo AM, Simbaña-Rivera K, Granizo-Martínez A, Pérez-M G, Moreno S, García-Cárdenas JM, Zambrano AK, Pérez-Castillo Y, Cabrera-Andrade A, Puig San Andrés L, Proaño-Castro C, Bautista J, Quevedo A, Varela N, Quiñones LA, Paz-Y-Miño C. In silico Analyses of Immune System Protein Interactome Network, Single-Cell RNA Sequencing of Human Tissues, and Artificial Neural Networks Reveal Potential Therapeutic Targets for Drug Repurposing Against COVID-19. Front Pharmacol 2021;12:598925. [PMID: 33716737 DOI: 10.3389/fphar.2021.598925] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
17 Sadarangani M, Marchant A, Kollmann TR. Immunological mechanisms of vaccine-induced protection against COVID-19 in humans. Nat Rev Immunol 2021;21:475-84. [PMID: 34211186 DOI: 10.1038/s41577-021-00578-z] [Cited by in Crossref: 276] [Cited by in F6Publishing: 268] [Article Influence: 138.0] [Reference Citation Analysis]
18 Al-Ansari MM, Sahlah SA, AlHumaid L, Ranjit Singh AJ. Probiotic lactobacilli: Can be a remediating supplement for pandemic COVID-19. A review. J King Saud Univ Sci 2021;33:101286. [PMID: 33519144 DOI: 10.1016/j.jksus.2020.101286] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]